Helen Boyd

2.2k citations

45 papers · 1.6k · h-index 20

Impact in

Cancer Research top 10%
- Protease and Inhibitor Mechanisms
Molecular Medicine top 10%

Papers in

Molecular Biology 23
- Protein Kinase Regulation and GTPase Signaling 7
- Ubiquitin and proteasome pathways 6
- Protein Degradation and Inhibitors 6
Hematology 5
- Multiple Myeloma Research and Treatments 4

Co-authors: David G. Tew (11 shared papers)Colin H. Macphee (10 shared papers)Kitty Moores (6 shared papers)Deirdre M. B. Hickey (7 shared papers)Colin A. Leach (9 shared papers)Robert J. Ife (10 shared papers)Kevin J. Milliner (7 shared papers)Keith E. Suckling (4 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (6 papers)Journal of Medicinal Chemistry (4 papers)Biochemical Journal (3 papers)Atherosclerosis (2 papers)Assay and Drug Development Technologies (2 papers)
Partner nations: United Kingdom United States Sweden

In The Last Decade

Helen Boyd

43 papers receiving 1.6k citations

Peers

Countries citing papers authored by Helen Boyd

Since Specialization

Citations

This map shows the geographic impact of Helen Boyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Boyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Boyd more than expected).

Fields of papers citing papers by Helen Boyd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Boyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Boyd. The network helps show where Helen Boyd may publish in the future.

Co-authors

The 25 scholars most cited alongside Helen Boyd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Helen Boyd Line = papers co-authored together Helen Boyd links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor Biochemical Journal ·Colin H. Macphee, Kitty Moores, Helen Boyd, Dash Dhanak, Robert J. Ife, Colin A. Leach, David S. Leake, Kevin J. Milliner, Rebecca A. Patterson, Keith E. Suckling, David G. Tew, Deirdre M. B. Hickey	1999	297
2	Proteolysis‐targeting chimeras in drug development: A safety perspective British Journal of Pharmacology ·Kévin Moreau, Muireann Coen, Andrew X. Zhang, Fiona Pachl, M. Paola Castaldi, Göran Dahl, Helen Boyd, Clay W. Scott, Pete Newham	2020	167
3	Purification, Properties, Sequencing, and Cloning of a Lipoprotein-Associated, Serine-Dependent Phospholipase Involved in the Oxidative Modification of Low-Density Lipoproteins Arteriosclerosis Thrombosis and Vascular Biology ·David G. Tew, Christopher Southan, Simon Q.J. Rice, G. M. Lawrence, Haodong Li, Helen Boyd, Kitty Moores, Israel Gloger, Colin H. Macphee	1996	140
4	The role of ATP citrate-lyase in the metabolic regulation of plasma lipids Biochemical Journal ·(unknown), John Yates, Theo A. Berkhout, Brian Jackson, David G. Tew, Helen Boyd, Patrick Camilleri, Patricia J. Sweeney, Andrew D. Gribble, Anthony N. Shaw, Pieter H.E. Groot	1998	125
5	Nanomolar Inhibitors of Staphylococcus aureus Methionyl tRNA Synthetase with Potent Antibacterial Activity against Gram-Positive Pathogens Journal of Medicinal Chemistry ·Richard L. Jarvest, John M. Berge, Valerie Berry, Helen Boyd, Murray J. B. Brown, John S. Elder, Andrew K. Forrest, Andrew Fosberry, Daniel R. Gentry, Martin Hibbs, Deborah D. Jaworski, Peter J. O’Hanlon, Andrew J. Pope, Stephen Rittenhouse, Robert J. Sheppard, Courtney Slater-Radosti, Angela Worby	2002	93
6	Identification of a Series of Tricyclic Natural Products as Potent Broad-Spectrum Inhibitors of Metallo-β-Lactamases Antimicrobial Agents and Chemotherapy ·David Payne, Juan A. Hueso-Rodríguez, Helen Boyd, N.O. Concha, Cheryl A. Janson, Martin L. Gilpin, John H. Bateson, C.A. Cheever, N.L. Niconovich, S. Pearson, Stephen Rittenhouse, David G. Tew, Emilio Dı́ez, Paloma Pérez, Jesús de la Fuente, Michael Rees, Alfonso Rivera‐Sagredo	2002	85
7	Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor Biochemical Journal ·Colin H. Macphee, Kitty Moores, Helen Boyd, Dash Dhanak, Robert J. Ife, Colin A. Leach, David S. Leake, Kevin J. Milliner, Rebecca A. Patterson, Keith E. Suckling, David G. Tew, Deirdre M. B. Hickey	1999	73
8	Making trans parents visible: Intersectionality of trans and parenting identities Feminism & Psychology ·Beth A. Haines, Alex A. Ajayi, Helen Boyd	2014	56
9	Treatment of rheumatoid arthritis with etanercept with reference to disease-modifying anti-rheumatic drugs: long-term safety and survival using prospective, observational data Lara D. Veeken ·Christopher Ll. Morgan, Paul Emery, Duncan Porter, Alan Reynolds, Andrew W. Young, Helen Boyd, Chris Poole, Craig J. Currie	2013	54
10	A CASE FOR SELF‐ASSESSMENT BASED ON RECENT STUDIES OF STUDENT LEARNING Assessment & Evaluation in Higher Education ·Helen Boyd, John Cowan	1985	43
11	Mechanism of Inhibition of LDL Phospholipase A₂ by Monocyclic-β-lactams. Burst Kinetics and the Effect of Stereochemistry Biochemistry ·David G. Tew, Helen Boyd, Stephen Ashman, Colin J. Theobald, Colin A. Leach	1998	37
12	Fluorescently Labeled Analogues of Dofetilide as High-Affinity Fluorescence Polarization Ligands for the Human Ether-a-go-go-Related Gene (hERG) Channel Journal of Medicinal Chemistry ·David H. Singleton, Helen Boyd, Jill Steidl‐Nichols, Matt Deacon, Marcel J. de Groot, David A. Price, David O. Nettleton, Nora K. Wallace, Matthew D. Troutman, Christine A. Williams, James G. Boyd	2007	35
13	Early evaluation of compound QT prolongation effects: A predictive 384-well fluorescence polarization binding assay for measuring hERG blockade Journal of Pharmacological and Toxicological Methods ·Matt Deacon, David H. Singleton, Nikki Szalkai, Rodger Pasieczny, Chris Peacock, David A. Price, James G. Boyd, Helen Boyd, Jill Steidl‐Nichols, Christine A. Williams	2006	33
14	Proteolysis Targeting Chimeras (PROTACs): A Perspective on Integral Membrane Protein Degradation ACS Pharmacology & Translational Science ·Camilla Ruffilli, Sascha Röth, Mónica Rodrigo, Helen Boyd, Noam Zelcer, Kévin Moreau	2022	33
15	Long-Term Drug Survival of TNF Inhibitor Therapy in RA Patients: A Systematic Review of European National Drug Registers International Journal of Rheumatology ·Anamika Arora, Anadi Mahajan, Dean Spurden, Helen Boyd, Duncan Porter	2013	31
16	Design of a Chemical Probe for the Bromodomain and Plant Homeodomain Finger-Containing (BRPF) Family of Proteins Journal of Medicinal Chemistry ·Niall Igoe, Elliott D. Bayle, C. Tallant, Oleg Fedorov, Julia Meier, P. Savitsky, Catherine Rogers, Yannick Morias, Sarah Scholze, Helen Boyd, Danen Cunoosamy, David Andrews, Anne Cheasty, Paul E. Brennan, Susanne Müller, Stefan Knapp, Paul V. Fish	2017	29
17	ATP-Citrate Lyase as a Target for Hypolipidemic Intervention. 2. Synthesis and Evaluation of (3R,5S)-ω-Substituted-3-carboxy-3,5-dihydroxyalkanoic Acids and Their γ-Lactone Prodrugs as Inhibitors of the Enzyme in Vitro and in Vivo Journal of Medicinal Chemistry ·Andrew D. Gribble, Robert J. Ife, Antony N. Shaw, David McNair, Christine E. Novelli, Susan Bakewell, Virendra P. Shah, Roland E. Dolle, Pieter H.E. Groot, (unknown), John Yates, David G. Tew, Helen Boyd, Stephen Ashman, Drake S. Eggleston, R. Curtis Haltiwanger, George Okafo	1998	27
18	Potent, orally active inhibitors of lipoprotein-associated phospholipase A2: 1-(biphenylmethylamidoalkyl)-pyrimidones Bioorganic & Medicinal Chemistry Letters ·Helen Boyd, Stephen C. M. Fell, Deirdre M. B. Hickey, Robert J. Ife, Colin A. Leach, Colin H. Macphee, Kevin J. Milliner, Ivan L. Pinto, D. Anthony Rawlings, Stephen A. Smith, Ian Stansfield, Steven J. Stanway, Colin J. Theobald, Caroline Whittaker	2002	25
19	natural product derived inhibitors of lipoprotein associated phospholipase a2, synthesis and activity of analogues of sb-253514 Bioorganic & Medicinal Chemistry Letters ·Ivan L. Pinto, Helen Boyd, Deirdre M. B. Hickey	2000	25
20	N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2 Bioorganic & Medicinal Chemistry Letters ·Helen Boyd, Stephen C. M. Fell, Sean T. Flynn, Deirdre M. B. Hickey, Robert J. Ife, Colin A. Leach, Colin H. Macphee, Kevin J. Milliner, Kitty Moores, Ivan L. Pinto, Rod A. Porter, D. Anthony Rawlings, Stephen A. Smith, Ian Stansfield, David G. Tew, Colin J. Theobald, Caroline Whittaker	2000	24

About Helen Boyd

Helen Boyd is a scholar working on Molecular Biology, Hematology, Pharmacology, Rheumatology and Genetics, having authored 45 papers that have together received 1.6k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (7 papers), Ubiquitin and proteasome pathways (6 papers), Protein Degradation and Inhibitors (6 papers), Multiple Myeloma Research and Treatments (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Blood disorders and treatments (4 papers), Structural Integrity and Reliability Analysis (3 papers) and Antioxidant Activity and Oxidative Stress (3 papers). The work is most often cited by research in Cancer Research (214 citations), Molecular Medicine (56 citations), Molecular Biology (759 citations), Biochemistry (60 citations) and Clinical Biochemistry (57 citations). Helen Boyd has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include David G. Tew, Colin H. Macphee, Kitty Moores, Deirdre M. B. Hickey, Colin A. Leach, Robert J. Ife, Kevin J. Milliner, Keith E. Suckling, David S. Leake and Rebecca A. Patterson. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Biochemical Journal, Atherosclerosis and Assay and Drug Development Technologies.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Helen Boyd

Impact in

Papers in i

In The Last Decade

Helen Boyd

Peers

Countries citing papers authored by Helen Boyd

Fields of papers citing papers by Helen Boyd

All Works

About Helen Boyd

Explore authors with similar magnitude of impact

Papers in